Literature DB >> 12500461

Prevalence and onset of rhinitis and conjunctivitis in subjects with occupational asthma caused by trimellitic anhydride (TMA).

Leslie C Grammer1, Anne M Ditto, Anju Tripathi, Kathleen E Harris.   

Abstract

Individuals with occupational asthma may also report symptoms of rhinitis or conjunctivitis. The objective of this study was to investigate the prevalence of rhinitis and conjunctivitis in subjects with occupational asthma as a result of trimellitic anhydride (TMA). Additionally, we wanted to evaluate the onset of rhinitis and conjunctivitis symptoms as compared with the occupational asthma symptoms. In a case series design, we studied 25 consecutive employees with TMA-induced asthma; each of them had participated in an annual surveillance program in which they were queried about rhinitis, conjunctivitis, and other respiratory symptoms. Twenty-two of the 25 (88%) reported rhinitis symptoms whereas 17 of the 25 (68%) reported conjunctivitis symptoms. In 17 of the 22 (77%) individuals with rhinitis and asthma, the rhinitis symptoms preceded the asthma symptoms. In 14 of the 17 (82%) individuals with conjunctivitis, those symptoms preceded the asthma symptoms. In summary, symptoms of rhinitis and conjunctivitis are common in subjects with occupational asthma because of TMA and often precede the respiratory symptoms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12500461     DOI: 10.1097/00043764-200212000-00013

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  9 in total

Review 1.  Diagnosis of occupational asthma: an update.

Authors:  Edgardo J Jares; Carlos E Baena-Cagnani; R Maximiliano Gómez
Journal:  Curr Allergy Asthma Rep       Date:  2012-06       Impact factor: 4.806

Review 2.  Occupational Rhinitis: Classification, Diagnosis, and Therapeutics.

Authors:  Zhisheng Shao; Jonathan A Bernstein
Journal:  Curr Allergy Asthma Rep       Date:  2019-11-27       Impact factor: 4.806

Review 3.  Evidence based guidelines for the prevention, identification, and management of occupational asthma.

Authors:  P J Nicholson; P Cullinan; A J Newman Taylor; P S Burge; C Boyle
Journal:  Occup Environ Med       Date:  2005-05       Impact factor: 4.402

Review 4.  Occupational rhinitis: an update.

Authors:  Whitney W Stevens; Leslie C Grammer
Journal:  Curr Allergy Asthma Rep       Date:  2015-01       Impact factor: 4.806

5.  Occupational asthma and occupational rhinitis: the united airways disease model revisited.

Authors:  Jacques Ameille; Karine Hamelin; Pascal Andujar; Lynda Bensefa-Colas; Vincent Bonneterre; Dominique Dupas; Robert Garnier; Brice Alain Loddé; Mickael Rinaldo; Alexis Descatha; Gérard Lasfargues; Jean-Claude Pairon
Journal:  Occup Environ Med       Date:  2013-02-06       Impact factor: 4.402

6.  Trimellitic anhydride induces low-grade mast cell degranulation without specific IgE.

Authors:  Kazuhiro Ogi; Tetsuji Takabayashi; Takechiyo Yamada; Masafumi Sakashita; Masafumi Kanno; Norihiko Narita; Shigeharu Fujieda
Journal:  Toxicol Rep       Date:  2016-09-07

7.  Evaluation of chemical-specific IgG antibodies in male workers from a urethane foam factory.

Authors:  Mayumi Tsuji; Yasuhiro Ishihara; Toyohi Isse; Chihaya Koriyama; Megumi Yamamoto; Noriaki Kakiuchi; Hsu-Sheng Yu; Masayuki Tanaka; Takuto Tsuchiya; Masanori Ohta; Rie Tanaka; Toshihiro Kawamoto
Journal:  Environ Health Prev Med       Date:  2018-06-19       Impact factor: 3.674

Review 8.  EAACI position paper on occupational rhinitis.

Authors:  Gianna Moscato; Olivier Vandenplas; Roy Gerth Van Wijk; Jean-Luc Malo; Luca Perfetti; Santiago Quirce; Jolanta Walusiak; Roberto Castano; Gianni Pala; Denyse Gautrin; Hans De Groot; Ilenia Folletti; Mona Rita Yacoub; Andrea Siracusa
Journal:  Respir Res       Date:  2009-03-03

9.  BSACI guidelines for the management of allergic and non-allergic rhinitis.

Authors:  G K Scadding; S R Durham; R Mirakian; N S Jones; S C Leech; S Farooque; D Ryan; S M Walker; A T Clark; T A Dixon; S R A Jolles; N Siddique; P Cullinan; P H Howarth; S M Nasser
Journal:  Clin Exp Allergy       Date:  2008-01       Impact factor: 5.018

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.